Hi-CRATES CO.,LTD.
Hiクラテス株式会社 Third Quarter Financial Summary〔Japanese GAAP〕for the Fiscal Year Ending September 2026
For the third quarter of the fiscal year ending September 2026, net sales were 191.43 million yen, operating income 50.7754 million yen, ordinary income 62.0242 million yen, and net income 41.3911 million yen, all significantly higher year over year. Full-year guidance remains unchanged at net sales of 2,484 million yen, ordinary income of 662 million yen, and net income of 451 million yen. ROE is 10.6%, PER 10.7x, and PBR 1.1x. The financial position shows total assets of 5,107.788 million yen and equity ratio of 86.2%.
Key Figures
- Net sales: 1,914,347千円（YoY +9.1％）
- Operating income: 507,754千円（YoY +21.9％）
- Ordinary income: 620,242千円（YoY +21.5％）
AI要約
Overview of performance
This financial summary reports the results for the third quarter, with net sales of 1,914 million yen, up 9.1% YoY; operating income of 507 million yen, up more than 20% YoY; ordinary income of 620 million yen; and net income of 414 million yen, all expanding. Profitability indicators are at high levels, with ROE at 10.6%, PER at 10.7x, and PBR at 1.1x, indicating peak profit levels. Full-year guidance is unchanged, and long-term goals for 2030 are stated.
Financial position and future strategy
Total assets stand at 5,108 million yen, with an equity ratio of 86.2%, and shareholders’ equity increasing to 440 million yen. Although dividend details are not specified, interim dividends were paid and retained earnings increased. The full-year forecast for the fiscal year ending September 2026 is net sales of 2,484 million yen, ordinary income of 662 million yen, and net income of 451 million yen, with a continued growth strategy through advancing dental medical DX initiatives.
Hiクラテス株式会社
Company overview · Stock price · Financial data · All IR
